Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vivarol is an oral dietary supplement developed by JBK Lab under the Cellmed brand, a South Korean pharmacy-exclusive nutritional line. The supplement is primarily formulated with krill oil, which is a rich source of omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as well as phospholipids and the potent antioxidant astaxanthin. Vivarol is marketed for general nutritional supplementation, with a specific focus on supporting cardiovascular health, maintaining healthy blood lipid levels, and providing antioxidant protection against cellular oxidative stress. It is delivered in a capsule format and is distributed through professional pharmacy channels to ensure guided consumer use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vivarol.